# ALS Group USA, Corp – FDA Inspection, Jan 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/877484d8-0afd-4c3e-ba4d-bf0238f90290
Source feed: FDA_Inspections

> FDA inspection 1077330 of ALS Group USA, Corp, January 25, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077330
- Company Name: ALS Group USA, Corp
- Inspection Date: 2019-01-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1334830 - 2026-09-04](https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/25be673d-1844-482e-9bc6-dfb3390de0b3)
- [FDA Inspection 1207264 - 2023-06-05](https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/76cf3ca1-c158-4027-82f2-8661490b459e)
- [FDA Inspection 1041299 - 2018-02-16](https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/ba612440-473d-46a8-b310-6574e9948d61)
- FDA Inspection 883899 - 2014-06-18
- FDA Inspection 770574 - 2012-03-01

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)
- [Issuing Officer](https://www.keypedia.com/people/carrie-a-hughes/099d1128-0ba9-4e7a-a0d2-8c10083811c9)

Company: https://www.keypedia.com/companies/als-group-usa-corp/6d3305d4-76a4-4d57-8ed6-1e636d486309

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b